US Broker Ratings

Verona Pharma plc (VRNA) Stock Analysis: Evaluating the Highs and Lows of a $9 Billion Biotech Powerhouse

Verona Pharma plc (NASDAQ: VRNA), a prominent player in the biotechnology sector with a market capitalization of $9.09 billion, is making waves with its innovative approach..

Insmed Incorporated (INSM) Stock Analysis: A Bold Bet on Biotech with a 10% Upside Potential

Investors in the biotechnology sector are always on the lookout for companies that combine cutting-edge research with strong market potential. Insmed Incorporated (NASDAQ: INSM) is one..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) stands as a notable player in the American healthcare plans sector, leveraging technology to innovate in the insurance landscape. The company,..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: An Investor’s Look at a Biotech with 66.8% Revenue Growth and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a name gaining momentum in the biotechnology sector, with its focus on rare neuroendocrine diseases. With a market cap of..

Qiagen N.V. (QGEN) Stock Analysis: Unlocking Potential with a 10% Upside in the Diagnostics & Research Sector

For investors eyeing the healthcare sector, Qiagen N.V. (NYSE: QGEN) represents a compelling opportunity within the diagnostics and research industry. Headquartered in Venlo, Netherlands, Qiagen specializes..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a Complex Valuation Landscape in Healthcare

Medpace Holdings, Inc. (NASDAQ: MEDP) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace offers..

Cytokinetics (CYTK) Stock Analysis: Exploring a 19.25% Potential Upside in the Biotech Sector

Cytokinetics, Incorporated (NASDAQ: CYTK) continues to be a focal point for investors eyeing the dynamic biotechnology sector. As a late-stage biopharmaceutical company, Cytokinetics is pioneering innovative..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 131.66% Potential Upside for Investors

Legend Biotech Corporation (NASDAQ: LEGN) has captured investor interest with a remarkable potential upside of 131.66%, as highlighted by current analyst ratings. Operating in the dynamic..

Bio-Techne Corp (TECH) Stock Analysis: Navigating Growth with an 8.41% Upside Potential

Bio-Techne Corporation (NASDAQ: TECH) stands at the intersection of the biotechnology and healthcare sectors, offering a blend of innovative solutions through its dual-segment operations. Headquartered in..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Navigating High Growth Potential in the Biotech Sector

Roivant Sciences Ltd. (ROIV), a London-based clinical-stage biopharmaceutical company, is making waves in the biotechnology industry. With a market capitalization of $13.65 billion, the company is..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating the Biotech Sector with a Promising MASH Treatment

Akero Therapeutics, Inc. (NASDAQ: AKRO) is gaining attention in the biotechnology sector with its cutting-edge approach to treating serious metabolic diseases. With a market capitalization of..

Globus Medical, Inc. (GMED) Stock Report: Navigating a 29% Potential Upside with Robust Revenue Growth

Investors eyeing opportunities in the healthcare sector may find Globus Medical, Inc. (NYSE: GMED) a compelling candidate. With a current market capitalization of $8.16 billion, this..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a Spanish multinational company, is a significant player in the healthcare sector, specializing as a drug manufacturer with a primary focus on..

BrightSpring Health Services, I (BTSG)

⚠️ No article content returned.

..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unveiling Growth Potential with a 9.10% Upside

Bausch + Lomb Corporation (NYSE: BLCO), a renowned name in the healthcare sector, is capturing investor interest with its promising outlook and significant market presence. Operating..

Baxter International Inc. (BAX) Stock Analysis: A 30% Upside Potential Amidst Market Challenges

Investors eyeing the healthcare sector may want to take a closer look at Baxter International Inc. (NYSE: BAX), a company renowned for its diverse portfolio of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Is an 8.9% Upside Worth Your Investment?

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector specializing in medical devices, stands as a pivotal entity in the life sciences and..

Centene Corporation (CNC) Stock Analysis: Navigating Growth Amidst a Shifting Healthcare Landscape

Centene Corporation (NYSE: CNC), a major player in the healthcare plans sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. With a..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 22% Potential Upside Amidst Robust Revenue Growth

Madrigal Pharmaceuticals, Inc. (MDGL), headquartered in West Conshohocken, Pennsylvania, stands out in the biotechnology sector with its focus on addressing metabolic dysfunction-associated steatohepatitis (MASH) through novel..

Incyte Corporation (INCY) Stock Analysis: Evaluating the Growth Potential Amidst a 20% Revenue Surge

Incyte Corporation (NASDAQ: INCY) stands out in the biotechnology industry with its impressive 20% revenue growth, positioning itself as a significant player in the healthcare sector...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds